Search

everythinglearnresearchcommunity

for

Search:↓

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

ICP5249 helps hair grow by activating a specific cell pathway.

Topical IKKα inhibitors may help prevent CCS tumours.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Targeting Keratin 17 may help overcome cancer therapy resistance.

CXCR2 in skin cells promotes tumor growth.

ATP-sensitive potassium channels are important for hair growth.

aPKCλ is crucial for keeping hair follicle stem cells inactive and maintaining normal hair growth.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Patched1 helps prevent tumors by controlling cell growth.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

QLT0267 stops hair follicle cell growth and movement.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Applying a specific inhibitor lightens skin and hair color.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.